Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
NDA User Fees Increasing 8.6% As FDA Projects More Applications But Fewer Sponsor Meetings
Jul 31 2025
•
By
Nielsen Hobbs
and
Derrick Gingery
US FDA uses multiple formulas to set its user fees, but the estimates it relies on that still make the numbers something of balancing act.
(Shutterstock)
More from Regulation
More from Policy & Regulation